Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

David N. Krag, Stewart Anderson, Thomas B. Julian et al. · The Lancet Oncology · 2010 · 1.9K citations · Full text

Medicine, Oncology, Surgery +17

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

Armando E. Giuliano, Karla V. Ballman, Linda McCall et al. · JAMA · 2017 · 1.9K citations · Full text

Medicine, Oncology, Surgery +16

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

Mila Donker, Geertjan van Tienhoven, Marieke E. Straver et al. · The Lancet Oncology · 2014 · 1.8K citations · Full text

Medicine, Oncology, Radiation Oncology +17

The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States

Karl Y. Bilimoria, Andrew K. Stewart, David P. Winchester et al. · Annals of Surgical Oncology · 2008 · 1.8K citations · Full text

Medicine, Health Care Management, Oncology +16

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer

Judy C. Boughey · JAMA · 2013 · 1.6K citations · Full text

Medicine, Oncology, Surgery +17